Transenterix (TRXC) Trading Down 6.5%
Shares of Transenterix Inc (NYSEAMERICAN:TRXC) were down 6.5% on Tuesday . The company traded as low as $2.02 and last traded at $2.03. Approximately 4,489,981 shares traded hands during trading, an increase of 39% from the average daily volume of 3,231,045 shares. The stock had previously closed at $2.17.
A number of analysts recently weighed in on the stock. Ladenburg Thalmann Financial Services set a $5.00 price objective on shares of Transenterix and gave the stock a “buy” rating in a report on Friday, October 20th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $4.00 price objective (up previously from $3.75) on shares of Transenterix in a report on Monday, October 30th. One research analyst has rated the stock with a sell rating, one has given a hold rating and two have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $2.61.
In other news, insider Todd Pope sold 600,000 shares of the firm’s stock in a transaction dated Wednesday, October 18th. The shares were sold at an average price of $3.68, for a total transaction of $2,208,000.00. Following the completion of the transaction, the insider now owns 462,644 shares in the company, valued at approximately $1,702,529.92. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Joseph P. Slattery sold 333,000 shares of the firm’s stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $2.93, for a total transaction of $975,690.00. Following the transaction, the chief financial officer now owns 440,974 shares of the company’s stock, valued at approximately $1,292,053.82. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,462,609 shares of company stock valued at $4,666,595.
A hedge fund recently raised its stake in Transenterix stock. Ladenburg Thalmann Financial Services Inc. grew its position in Transenterix Inc (NYSEAMERICAN:TRXC) by 87.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 79,150 shares of the medical instruments supplier’s stock after buying an additional 37,000 shares during the quarter. Ladenburg Thalmann Financial Services Inc. owned approximately 0.05% of Transenterix worth $113,000 at the end of the most recent quarter.
COPYRIGHT VIOLATION NOTICE: This report was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another website, it was illegally stolen and republished in violation of international copyright laws. The correct version of this report can be read at https://www.watchlistnews.com/transenterix-trxc-trading-down-6-5/1760114.html.
TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.
Receive News & Ratings for Transenterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix and related companies with Analyst Ratings Network's FREE daily email newsletter.